Science Outreach-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

International Life Extension Research Alliance

Domestic and International Exchange Dynamics

Video Center

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2026-04-13

→

From Nature Cover to Human Trial: The First Clinical Test for "Reversing Aging" Therapy Finally Begins

The "reversing aging" study that graced the cover of Nature six years ago has finally left the lab and entered human trials. A "partial reprogramming" gene therapy, co-developed by Yuancheng Lu, a former Chinese doctoral student in David Sinclair's lab at Harvard Medical School, has recently received FDA approval to launch the world's first human clinical trial targeting cellular aging reversal. This marks the first time the once sci-fi concept of "rejuvenation" will be scientifically tested in humans.

2026-04-13

→

Micro/Nano-Scale Cell Printing Precisely Regulates the Microenvironment to Achieve Tissue Functional Regeneration

As depicted in the review's future blueprint—from smart bioink preparation to hybrid printing processes and stimulated maturation and development—micro/nano-scale 3D bioprinting is steadily bringing the dream of "custom-made organs" closer to reality.

2026-04-02

→

World First! "Cyber Fly" Acts Autonomously with a Simulated Brain – How Far Are We from Replicating the Human Brain?

"This is not just about building robots, but also about treating diseases," Xu Chun reveals. His team is using such digital models to compare differences between diseased and healthy brain connections, precisely locating neural circuit abnormalities.

2026-03-24

→

Breakthrough "Freeze-and-Print" Technology Debuts: Novel Cryo-Bioink Solves the Challenge of Preserving Adherent Cells

The advent of the CAMP platform means that in the future, we may be able to "retrieve" pre-prepared cell-laden bioinks from cell banks as easily as taking out an ice cube, revive them, and immediately use them for 3D printing to construct tissue engineering scaffolds or even organ chips. This breakthrough technology offers a highly promising "ready-to-use" solution for the urgent repair of large tissue defects and the rapid fabrication of personalized implants in clinical settings, with the potential to completely bridge the critical gap from laboratory to operating room.

2026-03-24

→

"Reviving" Life on a Computer: The First Complete 4D Full-Cycle Simulation of a Minimal Genome Cell

Nonetheless, this newly opened window not only allows us to understand how the simplest form of life operates but also paves the way for simulating more complex human cells in the future.

2026-03-16

→

Unlocking the Heart's Code: Scientists Discover the Regenerative Seeds to Rejuvenate the Adult Heart

Professor Wang Wei emphasized that this study clarifies the mechanism of the decline in cardiac regeneration at the cellular subpopulation level, providing a brand-new target for myocardial regenerative therapy after MI. Although clinical application still needs to bridge the gap from basic research to translational medicine, this beam of scientific light has illuminated the path to recovery for tens of millions of MI patients.